Skip to main content

Table 1 Baseline characteristics of trial participants, by treatment group

From: Efficacy of fixed-dose combination artesunate-amodiaquine versus artemether-lumefantrine for uncomplicated childhood Plasmodium falciparum malaria in Democratic Republic of Congo: a randomized non-inferiority trial

  ASAQ AL  
Patients included 156 145 -
Age (months) 27.6 (6–59; 14.3) 27.4 (6–59; 15.0)  
Sex (female) 83 (53.3%) 69 (47.6%)  
Weight (kg) 10.3 (5.1-17.0; 2.7) 10.2 (5.3-16.0; 2.6)  
Axillary temperature (°C) 37.6 (34–40.5; 1.3) 37.6 (35.2-40.0; 1.1)  
Patients with fever (T° ≥ 37.5°C) 79 (50.6%) 71 (48.9%)  
Haemoglobinaemia (g/dL) 9.0 (4.0-13.3; 1.9) 9.0 (5.3-15.5; 2.1)  
Anaemia 5- < 8 g/dl 50 (32.0%) 51 (35.2%)  
8-11 g/dl 83 (53.2%) 65 (44.8%)  
> 11 g/dl 23 (14.8%) 29 (20.0%) -
Geometric mean parasite density (/μL) (IQR) 17111 (34674) 14886 (53420)  
Proportion ≥ 100,000 para/μL 13 (8.3%) 11 (7.5%)  
Patients with gametocytes 9 (5.8%) 7 (4.8%)  
  1. Data are number (%) or mean (range; SD), unless otherwise indicated.